Physician profile

Aurelius E Archie

General Practice (Dentist) · Stockbridge, GA

NPI 1548312986

$244.95

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$75.93

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Dentsply Sirona INC $78.51 2021-2023 Suresmile
Orapharma, A Division of Bausch Health US, LLC $58.73 2020-2024 Arestin
Zest Holdings, LLC $43.14 2024
Ultradent Products INC $20.09 2019
Philips North America LLC $14.33 2021
Straumann USA LLC $13.88 2020
Gc America INC. $11.68 2022
Ace Surgical Supply Co., INC. $4.59 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Aurelius E Archie

$244.95

in general payments reported 2019-2025

Years
2019-2024
Top company
Dentsply Sirona INC

https://glasscript.com/doctor/549587/aurelius-e-archie

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.